Evidence map›Paper›PMID 30102370›Full record

ArticleNucleic acids research2018

A two-nuclease pathway involving RNase H1 is required for primer removal at human mitochondrial OriL.

Ali Al-Behadili, Jay P Uhler, Anna-Karin Berglund, Bradley Peter, Mara Doimo, Aurelio Reyes, Sjoerd Wanrooij, Massimo Zeviani, Maria Falkenberg

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. How RNases Shape Mitochondrial Transcriptomes.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Identification and Characterization of NewFrontiers in genetics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ali Al-BehadiliDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, Sweden.
Jay P UhlerDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, Sweden.
Anna-Karin BerglundDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, Sweden.
Bradley PeterDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, Sweden.
Mara DoimoDepartment of Medical Biochemistry and Biophysics, Umeå University, 901 87 Umeå, Sweden.
Aurelio ReyesMRC-Mitochondrial Biology Unit, University of Cambridge, MRC Building, Hills Road, Cambridge CB2 0XY, UK.
Sjoerd WanrooijDepartment of Medical Biochemistry and Biophysics, Umeå University, 901 87 Umeå, Sweden.
Massimo ZevianiMRC-Mitochondrial Biology Unit, University of Cambridge, MRC Building, Hills Road, Cambridge CB2 0XY, UK.
Maria FalkenbergDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, Sweden.
University of Gothenburg · SEUmeå University · SEUniversity of Cambridge · GB

Funding

European Research Council 322424Medical Research Council MC_EX_MR/P007031/1Medical Research Council MC_UP_1002/1Medical Research Council MC_UU_00015/5Medical Research Council MC_UU_00015/7Medical Research Council MC_UU_00015/8
6 · The paper itself

Abstract

The role of Ribonuclease H1 (RNase H1) during primer removal and ligation at the mitochondrial origin of light-strand DNA synthesis (OriL) is a key, yet poorly understood, step in mitochondrial DNA maintenance. Here, we reconstitute the replication cycle of L-strand synthesis in vitro using recombinant mitochondrial proteins and model OriL substrates. The process begins with initiation of DNA replication at OriL and ends with primer removal and ligation. We find that RNase H1 partially removes the primer, leaving behind the last one to three ribonucleotides. These 5'-end ribonucleotides disturb ligation, a conclusion which is supported by analysis of RNase H1-deficient patient cells. A second nuclease is therefore required to remove the last ribonucleotides and we demonstrate that Flap endonuclease 1 (FEN1) can execute this function in vitro. Removal of RNA primers at OriL thus depends on a two-nuclease model, which in addition to RNase H1 requires FEN1 or a FEN1-like activity. These findings define the role of RNase H1 at OriL and help to explain the pathogenic consequences of disease causing mutations in RNase H1.

Indexed as

DNA, MitochondrialDNA ReplicationFlap EndonucleasesHumansMitochondriaMitochondrial ProteinsRecombinant ProteinsRibonuclease HRibonucleotidesRNADNA, MitochondrialFlap EndonucleasesMitochondrial ProteinsRecombinant ProteinsRibonuclease Hribonuclease HIRibonucleotidesRNARNA primers

Identifiers

PMID30102370
PMCPMC6182146
OpenAlexW2885962205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.